Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World study tracks quality of life in men on prostate cancer drug lutathera

NCT ID NCT06517719

Recruiting now Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 men with metastatic castration-resistant prostate cancer who are receiving lutetium-177 vipivotide tetraxetan (a radioactive drug) as part of their routine care. Researchers will measure quality of life, pain, and disease progression over time using patient questionnaires and medical records. The goal is to understand how this treatment works in real-world settings, outside of clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lutetium-177 vipivotide tetraxetan (a radioactive drug that targets prostate cancer cells)

What this could lead to

If successful, this study will provide real-world data on how this treatment affects quality of life and disease progression in everyday practice.

What could go wrong

This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and other treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Konstanz, Baden-Wurttemberg, 78464, Germany

  • Novartis Investigative Site

    RECRUITING

    Stuttgart, Baden-Wurttemberg, 70174, Germany

  • Novartis Investigative Site

    RECRUITING

    Munich, Bavaria, 81377, Germany

  • Novartis Investigative Site

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Novartis Investigative Site

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

  • Novartis Investigative Site

    RECRUITING

    Cottbus, Brandenburg, 03048, Germany

  • Novartis Investigative Site

    RECRUITING

    Frankfurt (Oder), Brandenburg, 15236, Germany

  • Novartis Investigative Site

    RECRUITING

    Ludwigshafen, Germany, 67063, Germany

  • Novartis Investigative Site

    RECRUITING

    Marburg, Hesse, 35043, Germany

  • Novartis Investigative Site

    RECRUITING

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Novartis Investigative Site

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Novartis Investigative Site

    RECRUITING

    Leipzig, Saxony, 04103, Germany

  • Novartis Investigative Site

    RECRUITING

    Halle, Saxony-Anhalt, 06120, Germany

  • Novartis Investigative Site

    RECRUITING

    Jena, Thuringia, 07740, Germany

  • Novartis Investigative Site

    RECRUITING

    Aachen, 52074, Germany

  • Novartis Investigative Site

    RECRUITING

    Augsburg, 86179, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 10249, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 12559, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 13125, Germany

  • Novartis Investigative Site

    RECRUITING

    Bielefeld, 33611, Germany

  • Novartis Investigative Site

    RECRUITING

    Bonn, 53105, Germany

  • Novartis Investigative Site

    RECRUITING

    Chemnitz, 09113, Germany

  • Novartis Investigative Site

    RECRUITING

    Dortmund, 44137, Germany

  • Novartis Investigative Site

    RECRUITING

    Dortmund, 44309, Germany

  • Novartis Investigative Site

    RECRUITING

    Erfurt, 99089, Germany

  • Novartis Investigative Site

    RECRUITING

    Erlangen, 91054, Germany

  • Novartis Investigative Site

    RECRUITING

    Essen, 45147, Germany

  • Novartis Investigative Site

    RECRUITING

    Fulda, 36043, Germany

  • Novartis Investigative Site

    RECRUITING

    Herford, 32049, Germany

  • Novartis Investigative Site

    RECRUITING

    Homburg, 66421, Germany

  • Novartis Investigative Site

    RECRUITING

    Magdeburg, 39120, Germany

  • Novartis Investigative Site

    RECRUITING

    Mainz, 55131, Germany

  • Novartis Investigative Site

    RECRUITING

    Nuremberg, 90419, Germany

  • Novartis Investigative Site

    RECRUITING

    Rostock, 18057, Germany

  • Novartis Investigative Site

    RECRUITING

    Trier, 54290, Germany

  • Novartis Investigative Site

    RECRUITING

    Tübingen, 72076, Germany

  • Novartis Investigative Site

    RECRUITING

    Ulm, 89081, Germany